Tirzah Petta has been appointed as Director of the USC Norris Molecular Genomics Core
Caryn Lerman, Director of Norris Comprehensive Cancer Center at Keck Medicine of USC, shared a post on LinkedIn:
“We are pleased to announce the appointment of Dr. Tirzah Petta, a cancer biologist and educator with expertise in molecular genetics, DNA damage response, and translational oncology, as Director of the USC Norris Molecular Genomics Core (MGC), effective April 1, 2025.
The mission of the MGC is to provide services for industry-standard and state-of-the-art molecular and genomic assays in support of USC Norris investigators working across the continuum of basic, translational, clinical and population sciences. The MGC scientific leadership works with USC Norris investigators on the planning, design, conduct, analysis, and reporting for molecular cancer research studies.
With strong expertise in genomics, Dr. Petta is dedicated to advancing the mission of MGC through her leadership. She looks forward to promoting services and providing scientific support for cutting-edge research projects within our community.”
More posts featuring Caryn Lerman.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023